Neurocentrx Closes Seed Extension Round Including Funding from the Wellcome Trust

Neurocentrx Pharma, a clinical-stage biopharmaceutical company pioneering safer, more accessible treatments for major mental health conditions, today announced the close of its seed extension funding ...
TipRanks on MSN

Lipocine Advances Phase 3 Trial for PPD Treatment

Lipocine ( ($LPCN) ) has provided an update. Lipocine Inc. announced progress in its Phase 3 clinical trial for LPCN 1154, an oral brexanolone ...
ksn.com

Head-to-head Trial of Prolonged-Release Oral Ketamine Formulation, KET01, and Intranasal SPRAVATO®, Finds Less Incidence of Dissociation or Cardiovascular Effects with Oral ...

MUNICH, Germany, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Ketabon GmbH (“Ketabon” or “the Company”), a joint venture between HMNC Brain Health and Develco Pharma, announced today favorable results from its ...
Business Wire

First Patient Dosed in Beckley Psytech’s International Phase IIb Study of BPL-003, a Novel Synthetic Intranasal Formulation of 5-MeO-DMT, for Treatment Resistant Depression (TRD)

OXFORD, England--(BUSINESS WIRE)--Beckley Psytech Ltd, a private, clinical-stage biotechnology company developing rapid-acting, short-duration psychedelic medicines for neuropsychiatric conditions, ...
Health on MSN

What Supplements Are Good for Depression?

Medically reviewed by Lindsay Cook, PharmD You may take vitamin D to help improve depression symptoms.Omega-3 fatty acids could have benefits for depression, but more research is needed.Keep in mind ...
Benzinga.com

NRx Pharmaceuticals (NASDAQ: NRXP) Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal Depression

The FDA designation expands the drug’s potential patient pool tenfold, to an estimated 13 million Americans who consider suicide annually. Clinical trials demonstrated rapid and statistically ...